{"xrefs":[],"alternate_symbols":[],"alternate_names":[],"attribute_content":[],"keywords":[],"id":"12757","type":"Disease","name":"Epidermolysis bullosa dystrophica, autosomal recessive, modifier of"}
{"xrefs":[],"alternate_symbols":[],"alternate_names":[],"medgen_id":"C1862326","attribute_content":[],"keywords":[],"id":"12870","type":"Disease","name":"Stomatocytic elliptocytosis, hereditary"}
{"xrefs":[],"alternate_symbols":[],"alternate_names":[],"attribute_content":[],"keywords":[],"id":"42084","type":"Disease","name":"Primary ciliary Dyskinesia"}
{"xrefs":["{\"db\":\"The Raphael Recanati Genetics Institute,Rabin Medical Center\",\"id\":\"SUB4493571\",\"ref_field\":\"name\"}"],"alternate_symbols":[],"alternate_names":[],"attribute_content":[],"keywords":[],"id":"41347","type":"Disease","name":"hepatic fibrosis"}
{"xrefs":["{\"db\":\"The Raphael Recanati Genetics Institute,Rabin Medical Center\",\"id\":\"SUB4493571\",\"ref_field\":\"name\"}"],"alternate_symbols":[],"alternate_names":[],"attribute_content":[],"keywords":[],"id":"41346","type":"Disease","name":"Cholestasis"}
{"xrefs":["{\"db\":\"Orphanet\",\"id\":\"602\"}","{\"db\":\"Orphanet\",\"id\":\"602\",\"ref_field\":\"name\"}"],"alternate_symbols":[],"alternate_names":["GNE-Related Myopathies"],"medgen_id":"CN924915","attribute_content":[],"keywords":[],"id":"38814","type":"Disease","name":"GNE myopathy"}
{"content":"{\"Citation\":[{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301439\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1262\",\"@Source\":\"BookShelf\"}]},{\"@Abbrev\":\"AAN, 2014\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"25313375\",\"@Source\":\"PubMed\"}}]}","xrefs":["{\"db\":\"OMIM\",\"id\":\"600737\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"600737\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"INCLUSION BODY MYOPATHY 2, AUTOSOMAL RECESSIVE\"}","{\"db\":\"OMIM\",\"id\":\"600737\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"QSM\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"9493\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"QSM\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Inclusion+body+myopathy+2/3793\",\"ref_field\":\"name\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"9493\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK1262\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"600737\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"alternate_symbols":["QSM"],"public_definition":"GNE-related myopathy, also known as inclusion body myopathy 2, is characterized by slowly progressive distal muscle weakness that begins in the late teens to early adult years with gait disturbance and foot drop secondary to anterior tibialis muscle weakness. Weakness eventually includes the hand and thigh muscles but commonly spares the quadriceps muscles, even in advanced disease. Affected individuals are usually wheelchair bound about 20 years after onset. If quadriceps sparing is incomplete, loss of ambulation tends to occur earlier.","alternate_names":["INCLUSION BODY MYOPATHY 2, AUTOSOMAL RECESSIVE"],"medgen_id":"C1833373","symbol":"IBM2","attribute_content":[],"keywords":[],"id":"2301","type":"Disease","name":"Inclusion body myopathy 2"}
